Call Number (LC) Title Results
HD9994.C6 Erfolgreicher Markteintritt in China für den deutschen Mittelstand (KMU). Am Beispiel der deutschen Medizintechnik. 1
HD9994 .C62 1994 Innovating for health : the story of Baxter International / 1
HD9994.U52 W45 2011eb Cost-contained regulatory compliance : for the pharmaceutical, biologics, and medical device industries / 1
HD9994.U54 B393 1990 Strategy of a megamerger : an insider's account of the Baxter Travenol-American Hospital Supply combination / 1
HD9995.C62 M56 1985 At any cost : corporate greed, women, and the Dalkon Shield / 1
HD9995.C64 A2343 1997 Unshielded : the human cost of the Dalkon Shield / 1
HD9995.C64 A236 1985 Nightmare : women and the Dalkon Shield / 1
HD9995.H423 U627 2018 Bad blood : secrets and lies in a Silicon Valley startup / 1
HD9995.H562 ǂb T46 2009eb Beyond the Gift Shop : Boost Revenue, Your Brand, and Patient Satisfaction with Strategic Hospital Retail. 1
HD9995.S24 K564 2004 Kotex, Kleenex, Huggies : Kimberly-Clark and the consumer revolution in American business / 1
HD9999 The Handbook of Managing and Marketing Tourism Experiences. 1
HD9999.A23 T95 1960 The Norton story / 1
HD9999.B163 N47 2008ev Gra Pala Ge / 1
HD9999.B44 HD9999.B442 B542 2005 HD9999.B442B542 2005 HD9999.B442 BioIndustry Ethics. 1
HD9999.B442 Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes /
Managing biotechnology : from science to market in the digital age /
2
HD9999.B442 .A978 2016 Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries : the Commercialization of Intellectual Property. 1
HD9999.B442 B47 2004eb Biotech industry : a global, economic, and financing overview / 1
HD9999.B442 B64 2008eb Valuation in life sciences : a practical guide / 1
HD9999.B442 B87 1991 Plants, power, and profit : social, economic, and ethical consequences of the new biotechnologies / 1
HD9999.B442 C663 2014 International Strategy and Market Performance in New Biotechnology Firms. 1